Jefferies Downgrades Enanta Pharmaceuticals (ENTA) to Hold, 'sidelines until we see real signs of progress'
Tweet Send to a Friend
(Updated - August 8, 2023 5:20 AM EDT)
Jefferies analyst Akash Tewari downgraded Enanta Pharmaceuticals (NASDAQ: ENTA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Akash Tewari downgraded Enanta Pharmaceuticals (NASDAQ: ENTA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
